{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:44:39Z","timestamp":1787496279539,"version":"build-2736575974"},"reference-count":18,"publisher":"Royal Society of Chemistry (RSC)","issue":"20","license":[{"start":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T00:00:00Z","timestamp":1758758400000},"content-version":"vor","delay-in-days":267,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/100000070","name":"National Institute of Biomedical Imaging and Bioengineering","doi-asserted-by":"publisher","award":["U54EB027690"],"award-info":[{"award-number":["U54EB027690"]}],"id":[{"id":"10.13039\/100000070","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["UL1TR002378"],"award-info":[{"award-number":["UL1TR002378"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["rsc.org"],"crossmark-restriction":true},"short-container-title":["Lab Chip"],"abstract":"<jats:p>Lucira health|innovation, rise, and fall.<\/jats:p>","DOI":"10.1039\/d5lc00305a","type":"journal-article","created":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T08:48:12Z","timestamp":1758790092000},"page":"5115-5121","update-policy":"https:\/\/doi.org\/10.1039\/rsc_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["From startup to shutdown: the dramatic rise and fall of the first at-home combo test for flu and COVID-19"],"prefix":"10.1039","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1569-5696","authenticated-orcid":false,"given":"Morgan N.","family":"Greenleaf","sequence":"first","affiliation":[{"name":"The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, Georgia, USA"},{"name":"Georgia Clinical and Translational Science Alliance, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2237-1713","authenticated-orcid":false,"given":"Gregory L.","family":"Damhorst","sequence":"additional","affiliation":[{"name":"The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, Georgia, USA"},{"name":"Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric M.","family":"Vogel","sequence":"additional","affiliation":[{"name":"The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, Georgia, USA"},{"name":"School of Materials Science and Engineering, Georgia Institute of Technology, Atlanta, GA, 30332, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9684-7593","authenticated-orcid":false,"given":"Greg S.","family":"Martin","sequence":"additional","affiliation":[{"name":"The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, Georgia, USA"},{"name":"Division of Pulmonary, Allergy, Critical Care, and Sleep Medicine, Department of Medicine, Emory University School of Medicine, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0325-7990","authenticated-orcid":false,"given":"Wilbur A.","family":"Lam","sequence":"additional","affiliation":[{"name":"The Atlanta Center for Microsystems-Engineered Point-of-Care Technologies, Atlanta, Georgia, USA"},{"name":"Division of Pediatric Hematology\/Oncology, Department of Pediatrics, Aflac Cancer Center and Blood Disorders Service of Children's Healthcare of Atlanta, Emory University School of Medicine, Atlanta, GA, 30322, USA"},{"name":"Wallace H. Coulter Department of Biomedical Engineering, Emory University and Georgia Institute of Technology, Emory University and Georgia Institute of Technology, USA"},{"name":"Georgia Clinical and Translational Science Alliance, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"292","published-online":{"date-parts":[[2025]]},"reference":[{"key":"D5LC00305A\/cit1\/1","volume-title":"FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses","year":"2023","unstructured":"FDA Authorizes First Over-the-Counter At-Home Test to Detect Both Influenza and COVID-19 Viruses ,  2023"},{"key":"D5LC00305A\/cit2\/1","volume-title":"Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process","year":"2023","unstructured":"Lucira Health to Pursue Strategic Sale of its Business Through Voluntary Chapter 11 Process ,  2023"},{"issue":"5","key":"D5LC00305A\/cit3\/1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1039\/C0LC00403K","volume":"11","author":"Dimov","year":"2011","journal-title":"Lab Chip"},{"key":"D5LC00305A\/cit4\/1","first-page":"240","volume-title":"Blue ocean strategy: how to create uncontested market space and make the competition irrelevant","author":"Kim","year":"2005","unstructured":"W. C.Kim  and  R. e.Mauborgne ,  Blue ocean strategy: how to create uncontested market space and make the competition irrelevant ,  Harvard Business School Press ,  Boston, Mass ,  2005 ,  p. 240"},{"issue":"4","key":"D5LC00305A\/cit6\/1","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.annemergmed.2017.09.010","volume":"71","author":"Frazee","year":"2018","journal-title":"Ann. Emerg. Med."},{"issue":"8","key":"D5LC00305A\/cit8\/1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1086\/598513","volume":"48","author":"Harper","year":"2009","journal-title":"Clin. Infect. Dis."},{"key":"D5LC00305A\/cit9\/1","volume-title":"Influenza Antiviral Medications: Summary for Clinicians","year":"2023","unstructured":"Influenza Antiviral Medications: Summary for Clinicians ,  2023 , Available from:  https:\/\/www.cdc.gov\/flu\/hcp\/antivirals\/summary-clinicians.html"},{"key":"D5LC00305A\/cit10\/1","volume-title":"Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test for Self-Testing at Home","year":"2020","unstructured":"Coronavirus (COVID-19) Update: FDA Authorizes First COVID-19 Test for Self-Testing at Home ,  2020"},{"key":"D5LC00305A\/cit11\/1","volume-title":"FORM 10-Q For the quarterly period ended March 31, 2022","year":"2022","unstructured":"FORM 10-Q For the quarterly period ended March 31, 2022 ,  2022"},{"key":"D5LC00305A\/cit12\/1","volume-title":"FORM 10-Q For the quarterly period ended June 30, 2022","year":"2022","unstructured":"FORM 10-Q For the quarterly period ended June 30, 2022 ,  2022"},{"key":"D5LC00305A\/cit13\/1","volume-title":"Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test","year":"2022","unstructured":"Lucira Announces Health Canada Authorization of First and Only 99% Accurate At-Home Covid & Flu Test ,  2022"},{"key":"D5LC00305A\/cit14\/1","volume-title":"Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing","year":"2023","unstructured":"Lucira Health Announces FDA Authorization of First & Only At-Home Combination Covid-19 & Flu Test and Comments on Chapter 11 Bankruptcy Filing ,  GLOBE NEWSWIRE ,  2023"},{"key":"D5LC00305A\/cit15\/1","volume-title":"CDRH Statement on Emergency Use Authorization of Lucira Health's COVID-19 & Flu Home Test","year":"2023","unstructured":"CDRH Statement on Emergency Use Authorization of Lucira Health's COVID-19 & Flu Home Test ,  2023"},{"key":"D5LC00305A\/cit16\/1","volume-title":"Pfizer to Shut Down Lucira Health Business by End of Q1","year":"2025","unstructured":"Pfizer to Shut Down Lucira Health Business by End of Q1 ,  2025 , Available from:  https:\/\/www.360dx.com\/molecular-diagnostics\/pfizer-shut-down-lucira-health-business-end-q1"},{"issue":"12","key":"D5LC00305A\/cit17\/1","first-page":"81","volume-title":"Exploit the product life cycle","volume":"43(6)","author":"Levitt","year":"1965","unstructured":"T.Levitt ,  Exploit the product life cycle ,  Harvard Business Review ,  1965 ,  vol. 43(6) ( 12 ),  pp. 81\u201394"},{"key":"D5LC00305A\/cit18\/1","volume-title":"FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis","year":"2025","unstructured":"FDA Grants Marketing Authorization of First Home Test for Chlamydia, Gonorrhea and Trichomoniasis ,  2025"},{"key":"D5LC00305A\/cit19\/1","volume-title":"Diffusion of Innovations","author":"Rogers","year":"2003","unstructured":"E. M.Rogers ,  Diffusion of Innovations ,  Free Press , 5th edn,  2003"},{"key":"D5LC00305A\/cit20\/1","volume-title":"Crossing the Chasm: Marketing and Selling Technology Project","author":"Moore","year":"2009","unstructured":"G. A.Moore ,  Crossing the Chasm: Marketing and Selling Technology Project ,  HarperCollins ,  2009"}],"container-title":["Lab on a Chip"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/pubs.rsc.org\/en\/content\/articlepdf\/2025\/LC\/D5LC00305A","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T03:38:37Z","timestamp":1782877117000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.rsc.org\/lc\/article\/25\/20\/5115-5121\/895275"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":18,"journal-issue":{"issue":"20","published-print":{"date-parts":[[2025,10,7]]}},"URL":"https:\/\/doi.org\/10.1039\/d5lc00305a","relation":{},"ISSN":["1473-0197","1473-0189"],"issn-type":[{"value":"1473-0197","type":"print"},{"value":"1473-0189","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025]]}}}